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The stratum corneum as the outermost epidermal layer protects against exsiccation and infection. Both the
underlying cornified envelope (CE) and the intercellular lipid matrix contribute essentially to these two main
protective barriers. Epidermis-unique ceramides with ultra-long-chain acyl moities (ULC-Cers) are key
components of extracellular lipid lamellae (ELL) and are bound to CE proteins, thereby contributing to the
cornified lipid envelope (CLE). Here, we identified human and mouse ceramide synthase 3 (CerS3), among
CerS1–6, to be exclusively required for the ULC-Cer synthesis in vitro and of mouse CerS3 in vivo.
Deficiency of CerS3 in mice results in complete loss of ULC-Cers (≥C26), lack of continuous ELL and a
non-functional CLE. Consequently, newborn mutant mice die shortly after birth from transepidermal water
loss. Mutant skin is prone to Candida albicans infection highlighting ULC-Cers to be pivotal for both barrier
functions. Persistent periderm, hyperkeratosis and deficient cornification are hallmarks of mutant skin dem-
onstrating loss of Cers to trigger a keratinocyte maturation arrest at an embryonic pre-barrier stage.
INTRODUCTION
The multilayered epidermis of mammalian skin represents the
first protective barrier towards environment. When the two
main barrier functions against transepidermal water loss
(TEWL) and pathogen invasion become deficient, such as in
ichthyosis, atopic dermatitis and psoriasis, specific, indispens-
able barrier components of the cornified epidermal layer, par-
ticularly the cornified envelope (CE) and the extracellular lipid
lamellae (ELL), are severely altered. Intracellularly, lipid pre-
cursors of the ELL are packed into membrane-limited, tubulo-
vesicular lamellar bodies (LBs) during keratinocyte
maturation together with a variety of proteins, including
hydrolytic enzymes and antimicrobial peptides. LBs are
preferentially extruded at the interface between the viable
and anuclear epidermal layers, i.e. the stratum granulosum
(SG) and the stratum corneum (SC), respectively. A key regu-
lator of this secretory process is an extracellular calcium gra-
dient (1,2).
Alignment of LB content into mature ELL requires sequen-
tial extracellular processing of lipid precursors, glucosylcera-
mides (GlcCers) and phospholipids, and establishment of the
cornified lipid envelope (CLE), a lipid monolayer covalently
bound to the CE and crucial for the competence of the water
permeability barrier (WPB). ELL contain high levels of Cers
with ultra-long-chain (ULC) (C28–C36) omega-hydroxylated
acyl moieties (abbreviated here as vh-Cers) (1), which are to a
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great extent v-esterified either to fatty acids (FAs), predomin-
antly linoleic acid or to carboxylic acid moities of cross-linked
CE proteins forming the CLE. During terminal cornification,
vh-Cers are degraded to yield the corresponding FAs and
sphingosine (3). Importantly, the latter has been shown to
have anti-microbial activity in vitro (4–7). Details of
vh-Cer biosynthesis and their intracellular transport as well
as the biogenesis and secretion of LBs are incompletely under-
stood at a molecular level. However, definite knowledge of
these processes and their regulation is of fundamental import-
ance for understanding skin pathophysiology, a prerequisite
for targeted therapy.
The biodiversity of Cer species arising in human SC from
12 subclasses (8) requires a family of genes, the CERS
family (Cers1–6 in mammals) (9). Depending on the substrate
specifity towards the length of the acyl-CoAs and the degree of
saturation, each of these enzymes synthesizes a subset of Cer
species. Whereas CerS have been identified for the incorpor-
ation of long-chain (LC, C16–20) and very long-chain
(VLC, C22–26) acyl moieties (10), a distinct member for
ULC-acyl CoA substrates (.C26) remains elusive.
The prominent coexpression of CerS3 and of ULC-
sphingolipids (ULC-SLs) in skin and testis suggested CerS3
in the biosynthesis of vh-Cers in the epidermis (11–13).
Here, we show by expressing CerS3 in yeast and human cell
cultures and by analyzing the epidermal lipids of CerS2- and
CerS3-deficient mice that CerS3 function cannot be replaced
by one of the other five CerS. Evidence is provided that
CerS3-deficient mice lack all SLs with ULC-FAs resulting
in WPB disruption, and that mutant skin enables pathogen in-
vasion (Candida albicans). We demonstrate absence of
vh-Cers to trigger an epidermal maturation arrest at an embry-
onic pre-barrier stage. Hallmarks of CerS3 mutant mouse skin
include discontinuity of ELL, impairment of CLE as shown
with unmasked loricrin, hyperkeratosis, persistence of peri-
derm and non-peripheral corneodesmosomes (CDs) and de-
fective profilaggrin processing. Our data demonstrate
ULC-Cers to be engaged in cornification and apoptosis of peri-
dermal cells.
RESULTS
Ultra-long-chain FAs are bona fide substrates of CerS3
From CerS1–6, only CerS2 and CerS3 accept VLC acyl-CoAs
(C22–C26) for the (dihydro-)Cer synthesis (11). To prove
our hypothesis CerS3 to be needed for ULC-Cer production,
a non-radioactive and detergent-free enzymatic assay with a
range of FAs including ULC-FA montanic acid (28:0), were
performed in living HeLa cells and yeast expressing CerS2
or CerS3. In HeLa cells, mCerS3-enhanced green fluorescent
protein (EGFP) localized to the endoplasmic reticulum (ER),
but not to the Golgi or lysosomes (Fig. 1A1–3). This expres-
sion is in line with the described acylation of sphingoid
bases at the ER (10).
Endogenously, HeLa cells express all Cers mRNAs except
for Cers3 mRNA. The major transcripts were those of
Cers2, consistent with the main Cer species containing
C24:0. HeLa cells exposed to an acyl-CoA mixture (16–
28:0-CoA) strongly synthesized Cers with cerotoyl (26:0)
and montanoyl CoA (28:0) (25% of total Cers) only upon
induction of the transfected human and murine CerS3. The ab-
solute cerotoyl-Cer amount was increased by 6-fold, while
montanoyl Cer was increased at least 16-fold in case of
hCerS3. With shorter acyl-CoAs, no increased incorporation
was observed in the presence of CerS3. Cells overexpressing
CerS2 or EGFP did not generate significant amounts of
ULC-Cers (Fig. 1B–E).
The preference of CerS3 and the inability of CerS2 to
accept ULC-acyl donors were confirmed in Saccharomyces
cerevisiae synthesizing montanoyl CoA upon transformation
with a mutant elongase protein (Sur4p∗) (14). The Cer-anchor
pattern of the downstream product inositolphosphorylceramide
(IPC) was analysed in strains in which the yeast homologues,
LAG1 and LAC1, were exchanged for CerS2 or CerS3 under
control of a yeast promoter. Montanoyl CoA was incorporated
into IPC in the CerS3 strain, but not in the CerS2 strain con-
firming that montanoyl CoA is a bona fide substrate of CerS3.
In addition, CerS3 accepted stearyl CoA (C18:0), lignoceroyl
CoA (C24:0) and cerotoyl CoA (26:0) (Fig. 1F and G).
CerS2 is not involved in ULC-ceramide synthesis in vivo
Although CerS2 was excluded for ULC-Cer synthesis in vitro,
its mRNA level was high in murine skin (Supplementary Mater-
ial, Fig. S1A). However, CerS2gt/gt mice show no obvious skin
phenotype and similar levels of epidermal Cer species, not
even for Cer containing a lignoceroyl residue (24:0), the pre-
ferred product of CerS2 (Supplementary Material, Fig. S1B–
C). Our results point to an indispensable role of CerS3 and
exclude CerS2 from VLC/ULC Cer synthesis in epidermis.
CerS3 deficiency in mice leads to WPB disruption and
neonatal death
To gain insight into the function of CerS3 in vivo, we gener-
ated mice with a disrupted Cers3 gene. Phenotypically,
CerS3d/d mice were easily distinguished from CerS3+/d and
CerS3+/+ mice, as their skin appeared unwrinkled, erythema-
tous and sticky (Fig. 2A). Milk in the stomach of newborns
(Fig. 2B) was only observed in controls consistent with the ob-
servation that the mother rejected mutant siblings. They died
Figure 1. CerS3 is located at the ER and synthesizes ULC-Cers in HeLa cells and in yeast. (A1–3) mCerS3-EGFP colocalizes with the ER marker (Pdi), but not
with those for Golgi (Golga1) or lysosomes (Lamp1). Nuclei, 4′,6-diamidino-2-phenylindole (DAPI). (B) Relative de novo Cer (d17:1) levels according to the
length of their FA moieties in cells either not expressing (2) or expressing (+) recombinant hCerS2 or hCerS3, or (D) mCerS3 or EGFP control. Lipids were
isolated 20 h after incubation with a saturated acyl-CoA mixture (C16, 18, 24, 26, 28-acyl-CoA) and sphingosine (d17:1). (C) Corresponding absolute concen-
trations of C26:0-Cer and (E) C28:0-Cer. (F) Relative IPC levels of wild-type (WT), mCerS2 and hCerS3 expressing S. cerevisiae transformed with WT (Sur4p)
or mutant FA elongase (Sur4p∗), the latter capable of C28:0-CoA synthesis. (G) Relative C26:0- and C28:0-IPC levels from mCerS2 and hCerS3 expressing cells
after transformation with Sur4p or Sur4p∗.
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Figure 2. Defective epidermal barrier and absence of CerS3. (A) Neonatal CerS3d/d skin appears erythematous when compared with controls. (B and C) Mayer’s
hemalaun exclusion assay demonstrates defective epidermal barrier in both mutant newborns and embryos (E18.5+0.5). (D and E) Significant increase in
TEWL and reduced body wet weight in mutants are evident about 3 h after birth. (F) Dry body weights of mutant and control embryos (E18.5+0.5) do
not differ. (G and G′) Endogenous CerS3 appears clustered within upper SS and SG, whereas in mutants CerS3 is absent. Nuclei, DAPI. (H and H′) Semithin
sections from neonatal control and mutant skin reveal thickened compact SC covered by a periderm (red arrows), and smaller KGs (yellow arrows) in mutants.
PAS-methylene blue/azure II (I and I′) EM of the upper epidermal layers exhibit SC lipid lacunae (yellow arrowheads), absent stratum disjunctum and periderm
on top of SC in mutants. The uppermost SC layer is marked by electron-lucent inclusion bodies in both controls and mutants (red double arrowheads). OsO4/
tannin.
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within 3–4 h after birth and/or were devoured by the mother.
It is reported that normal newborns which are not fed survive
at least three times longer (12–24 h) than observed for CerS3
mutants excluding malnutrition as a cause for their neonatal
death (15).
As the erythematous appearance suggested a compromised
epidermal barrier, permeability assays were carried out.
Mutants exhibited a strong dye penetration, indicating
barrier impairment at birth and at embryonic stage (E18.5).
The WPB is normally established between E17.5 and E18.5
(16) and indeed E18.5 controls were resistant to dye penetra-
tion (Fig. 2B and C). The permeability defect was corrobo-
rated by over 2-fold increased TEWL rates (Fig. 2D). As no
differences in wet or dry body weight of E18.5 mutant and
control embryos were found (Fig. 2F and Supplementary Ma-
terial, Fig. S2F), the 30% decrease in body wet weight of
newborn mutants (Fig. 2E) resulted obviously from desicca-
tion. Keeping these data in mind, all studies were carried
out in newborns directly after birth.
CerS3 localizes to upper stratum spinosum (SS) and SG
In order to confirm the loss of CerS3 in mutant skin at the
protein level, we determined the epidermal localization of
CerS3-dependent Cer synthesis. CerS3 clustered in scattered
dots within keratinocytes of upper SS and SG. In contrast,
CerS3 expression was not detected in mutants (Fig. 2G and
G′), thereby indicating that deletion of exon 7 renders synthe-
sis or stability of mutated CerS3 dysfunctional.
Epidermal maturation arrests at embryonic pre-barrier
stage
To find out the cause of skin stickiness, mutant epidermal
structure was analyzed after embedding skin in agar
before sample processing. This approach provided an intact
periderm on top of mutant SC. This protective embryonic
cell layer, which is normally degraded in parallel to barrier
formation, failed to shed in CerS3-depleted epidermis
at E18.5 and P0 (Fig. 2H–I′, Supplementary Material,
Figs S2I–J′ and S5A′).
Below the periderm, mutant SC was almost twice as thick
with 40% more corneocyte layers constituting only a
stratum compactum, but lacking a stratum disjunctum
(Fig. 2H–I′ and Supplementary Material, Fig. S2I–J′). This
hyperkeratosis appeared neither to result from altered des-
quamation or enhanced proliferation, as (i) corneocyte shed-
ding had not taken place even in controls, as confirmed by
the presence of the outermost corneocyte layer decorated
with electron-lucent, F-actin-positive inclusion bodies
(Figs 2I and I′ and 6B and B′), and (ii) the proliferation rate
of basal keratinocytes was unchanged (Supplementary Mater-
ial, Fig. S2M–N′) as proven by the distribution pattern of both
Ki67 within interfollicular epidermis and cytokeratins Krt14
and Krt10 in the basal and suprabasal layers, respectively
(Supplementary Material, Fig. S2K–L′). Hyperkeratosis was
already obvious at E18.5 (Supplementary Material, Fig. S2J
and J′), suggesting a failure in barrier formation to trigger
mildly enhanced keratinocyte proliferation before birth.
Antimicrobial barrier is disturbed
Increased TEWL values and reduced epidermal Cer levels are,
for example, described in patients with atopic dermatitis,
highly susceptible for pathogen infection (4). Therefore, we
tested whether the skin barrier of CerS3d/d mice was also
prone to infections. As a model, we inoculated cultured skin
samples of newborns with C. albicans, a common opportunis-
tic pathogen colonizing the epidermis of patients with compro-
mised skin integrity.
In contrast to controls, prominent pathogen adhesion to
mutant SC was visible as early as 6 h after inoculation. As a
result, focal proliferation of C. albicans and deep invasive in-
fection into all epidermal layers was observed after 24 h
(Fig. 3A–B′). At 66 h, increased colony formation occurred
within lower epidermal layers, and additionally pseudohyphae
that crossed the residual basement membrane migrated deep
into the dermis which was marked by abundant immune
cells (Fig. 3C′). This enhanced fungal attack was confirmed
in E18.5 mutant embryos by the determination of the colony
forming units (Supplementary Material, Fig. S2O).
Besides sphingosines, specific antimicrobial peptides are
involved in cutaneous defense mechanisms against pathogens.
These peptides are generally packed in LBs and extruded at
the SG–SC interface (17,18). In mutant skin, a downregula-
tion of antimicrobial peptide synthesis at the transcriptional
level was not observed for b-defensins and cathelicidin (Sup-
plementary Material, Fig. S2P), suggesting a direct inhibitory
effect of sphingosine on Candida growth and invasion.
ULC ceramides are absent
We used thin layer chromatography (TLC) and quantitative
mass spectrometry (MS) to evaluate the effects of CerS3 de-
pletion on the epidermal lipid composition. TLC revealed
that all Cer and GlcCer bands except the correspondingly
lowest band were strongly reduced or absent in CerS3d/d
mice. No significant differences could be observed between
wild-type and heterozygous mice (Supplementary Material,
Fig. S3A). MS further showed that all Cer, GlcCer and sphin-
gomyelins with C26:0 or ULC-FA residues were lost. Since
SLs with ULC-acyl moieties are the only sources of
vh-esterified SLs, all protein-bound Cers and all Cers
vh-esterified with linoleic acid were missing. Surprisingly,
even SLs with lignoceroyl (24:0) residues were significantly
diminished. Cer and GlcCer containing (hydroxylated) palmi-
tate (16:0 or h16:0) residues were slightly elevated confirming
TLC data. However, this increase did not compensate for the
loss of ULC-SLs indicating CerS3d/d mice lack in total
90% of all epidermal Cers (Fig. 4C–F and Supplementary
Material, Fig. S3B). Along with cornification, Cers are
degraded to sphingosines and FAs. In line with lost Cers, we
observed a decrease in sphingosines to 10% of control
levels using a new MS assay (unpublished data).
Lipid barrier is disrupted, but corneocyte plasma
membrane structure is conserved
GlcCers and phospholipids, including sphingomyelins, are
precursors of Cers and free FAs. Together with cholesterol,
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they are major ELL constituents. Present in an almost equimo-
lar ratio, they are considered crucial for ELL organization and
barrier competence. To assess the relevance of ULC-Cers for
alignment of continuous ELL and establishment of CLE, we
analyzed cholesterol (filipin) as well as neutral and polar
lipid (Nile red) localization in correlation to the epidermal
fine structure. Filipin and Nile red decorated corneocytes
with uniform linear lipid structures throughout SC (Fig. 4A
and B). In mutants, however, an abnormal, pearl-like lipid dis-
tribution was obvious (Fig. 4A′ and B′). The ultrastructural
analysis confirmed the loss of lamellar structures within the
upper SC. Minor amounts of secreted lipid clustered into
small lentil-like lacunae (Figs 2I′ and 4H′ –G′, and Supple-
mentary Material, Fig. S5A′) often located at tricellular
contact sites. Surprisingly, in the lower SC interstices and
the interface, areas with ELL were observed in mutants
(Fig. 4I1–3
′ and J′). ELL appeared similar, independent of
the postfixation method used (Fig. 4I1–2 and J1–2, compare
with mature LBs in Supplementary Material, Fig. S3C1–3).
These ELL alternated with ELL-free areas (Fig. 4H′ and I3′)
suggesting insufficient lipid secretion by LBs at the mutant
interface. Indeed, the latter appeared flattened, whereas in
controls the interface was marked by deep invaginations
filled with lamellar stacks reflecting abundant exocytosis
(Fig. 4H and I1,). As a consequence, in mutant SC, the trilami-
nar plasma membrane structure of 8 nm in width persisted
not only at the interface (Fig. 4I3
′), but also in the upper
layers of SC (Fig. 4G′ and Supplementary Material, Fig.
S5B′ and C′), including the outermost corneocyte layer
(Fig. 6F1
′). Thus, the loss of ULC-Cers leads to impaired
CLE and pore-like, ELL-free SC interstices responsible for
enhanced TEWL.
Biogenesis and extrusion of LBs are accelerated
We next asked whether reduced secretion resulted from defi-
cient intracellular LB formation. Besides lipids, lysosome-
related LBs secrete lipases and proteases such as kallikrein 5
(Klk5) and cathepsin D (Ctsd) (19). Ctsd was used to trace
LB distribution.
In controls, Ctsd labeled with high intensity the secretory
front at the SG–SC interface and the sub-adjacent, uppermost
Figure 3. High skin susceptibility to Candida infection. (A–C′) Cultured skin samples of CerS3d/d mice reveal after inoculation with C. albicans increased
microbial adhesion and growth after 6 h (A′), microbial invasion of all epidermal layers after 24 h (B′) and microbial colony formation within SS in parallel
to migration of pseudohyphae into the dermis after 66 h (C′, the residual basement membrane, red arrowheads). Note the abundance of immune cells in
mutant dermis after 66 h. PAS-hemalaun.
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SG layer. In mutants LB release, as monitored by Ctsd, was
weak at the interface, but a new front located to the lower
SG/SS as unequivocally confirmed by consecutive sections
(Fig. 5A1–2 and A
′
1–2). Concomitantly, Ctsd present in
normal SC was lacking in mutant SC (Fig. 5A and A′), al-
though prepro-Ctsd processing (unpublished data) and
overall mature protein levels, similar to Klk5, were not
altered (Fig. 7F). Fine structural analysis confirmed that in
controls the greatest amount of LB exocytosis was found at
the interface and unreleased LBs peaked at the apical
surface of the second uppermost SG keratinocytes. In
mutants, however, LB extrusion was limited at the interface
and the highest number of unreleased LBs was detected
within the third/fourth SG layer (Fig. 5D–E′), indicating
both premature LB formation and accelerated LB release.
The quantity of LBs seemed similar in mutants (Fig. 5E and
E′), whereas the diameter of LBs was slightly decreased and
enclosed lamellar stacks were often shortened and fragmented
(Fig. 5E and E′, insets).
Abundant tubular–vesicular structures with similar dimen-
sions as LBs were observed even within the uppermost SG,
but were not altered ultrastructurally in mutants. To verify
that these structures were not related to LBs, but represent per-
oxisomes, we tracked them using the peroxisomal
membrane-anchored protein Pex14, a key component of the
peroxisomal import machinery (20) and diaminobenzidine
(DAB) for EM visualization of catalase. Abundance and
shape of peroxisomes were confirmed by DAB (Fig. 5CTEM
for control). Pex14 staining revealed similar peroxisome
density, but the peroxisome signal remarkably declined in
mutant SG (Fig. 5C and C′). The proximity of LBs and peroxi-
somes in SG as well as a likely decreased peroxisomal import
activity in mutants hints to a potential involvement of peroxi-
somes in vh-Cer biosynthesis which remains to be clarified.
Non-peripheral CDs are preserved
A key question remained: how does CerS3 deficiency cause an
arrest in SC maturation leading to cohesion of uppermost cor-
neocytes and periderm? CDs as intercellular junctions are
crucial in SC cohesion and proteases including Ctsd are
required for their degradation (21). In the outer layers
(stratum disjunctum), non-peripheral CDs are degraded
leading to the typical ‘basket-weave’ appearance of control
skin (Figs 2H and 3A–C). Both cohesion and degradation
are controlled by pH, which decreases in the upper SC (22).
Surprisingly, preliminary surface measurements on newborns
showed a pH increase from 5.2+ 0.1 to 5.8+ 0.2 in
mutants. As suggested, EM analysis revealed peripheral and
non-peripheral CDs persisted in all mutant SC layers (Supple-
mentary Material, Fig. S5A′), including the most superficial
one (Fig. 6F′1–2). Transformation of a desmosomal core into
a homogeneous, electron-dense desmoglea was not observed
(Supplementary Material, Fig. S5B–C′). In controls, non-
peripheral CDs were restricted to stratum compactum and
were lacking between uppermost SC layers (Fig. 6F). Corres-
pondingly, desmoglein 1—a Ca2+-dependent, cell bridging
transmembrane cadherin and major component of suprabasal
desmosomes and CDs—was preserved in mutant SC, includ-
ing periderm visualizing thereby all CDs. In control SC, des-
moglein 1 was not detected, even after alkaline treatment
(Fig. 6A and A′) either due to masking or restricted degrad-
ation of the cytosolic desmoglein 1 domain, detected by the
antibody. Nevertheless, the overall protein levels decreased
in CerS3d/d epidermis (Fig. 7F). The desmosomal plaque pro-
teins, desmoplakin 1/2 (Fig. 6E and E′) and plakoglobin (un-
published data), were not detectable in mutant and control
SC implicating their degradation.
Peridermal cells, still containing nuclear remnants
(Fig. 6D′) and occasionally cell organelles, were intercon-
nected by desmosomes (Fig. 6F′3–4) and to SC by CDs
(Fig. 6F′2). Additionally, TJs described for embryonic peri-
derm (23) persisted between peridermal cells (Fig. 6C′ and
F′4). In controls, TJs were restricted to SS/SG, forming in
the upper SG continuous linear structures (zonulae occlu-
dentes) which essentially contribute to the WPB (Fig. 6D)
(24). Although no differences were observed for claudin-1
(Figs 6C and C′ and 7F), slightly thickened and curled
strands were observed in mutant SG when labeled with cingu-
lin, a TJ-associated protein (Fig. 6D′). Thus, TJs appeared
functional and are not the cause of WPB disruption in
CerS3d/d mice.
Keratinocyte cornification is delayed
The transition of SG keratinocytes to corneocytes is precisely
controlled accompanied by conspicuous morphological
changes, including formation of a condensed cytokeratin fila-
ment network and CE parallel to degradation of nuclei, orga-
nelles and plasma membrane. To assess whether the final
cornification arrest is triggered by a delay of earlier maturation
steps, we analyzed the keratohyalin granule (KG)
Figure 4. Impaired SC lipid organization and epidermal lipid composition. (A and B′) Both cholesterol labeling with filipin (A and A′) and staining of polar and
neutral lipids with Nile red (B and B′) reveal continuous linear lipid structures in control SC (A and B) which are replaced by a dot-like pattern in mutants (A′ and
B′, white arrows). (C–F) MS quantification of epidermal Cers (C and F), GlcCers (D) and sphingomyelins (E, SM) of CerS3+/+, CerS+/d and CerSd/d mice
indicates loss of all SLs with acyl moieties longer than 24 C-atoms in mutants, including all SLs bound to linoleic acid or proteins. Cers with C24-acyl moieties
are also significantly reduced (F). Non-esterified SLs (free) with acyl moieties smaller than 28 C-atoms (FA ≤ C26) or longer than 26 C-atoms (FA ≥ C28); EOS,
SLs esterified to linoleic acid; POS, protein-bound SLs. (G′, H–J′) EM of SG and SC. (G′) Mutant upper SC interstices show highly approximated, ELL-free
domains (yellow arrows) between adjacent corneocytes alternating with non-peripheral CDs (black arrows) or with focal, lentil-like lipid agglomerates (black
asterisk) present from the second SC layer onwards (H′, red asterisks). (H and H′) SG–SC interface in controls exhibits abundant LB exocytosis marked by deep
invaginations (red arrows), absent in mutants. Lamellar lipid-free domains exclusively occur in mutants (yellow arrows). (I–J′) Higher magnification reveals
secreted lipid stacks in both controls and mutants. Mutant discs are rather shorter but arrange similar in parallel to the cell surface. (I′3, inset) At high magni-
fication, the trilaminar plasma membrane structure (b) of 8 nm thickness spaced by two electron-dense bands corresponding to the polar lipid head groups is
clearly visible at the lamellar lipid-free interface (i). (G′ –I′) OsO4/tannin and (J–J′) RuO4 postfixation. (J′) Red arrow, desmosome; red asterisk, lamellar
discs at a tricellular contact site.
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compartment. KGs were located within the SG and composed
of large F-granules (profilaggrin) and small L-granules (lori-
crin). Mutants exhibited a marked reduction in size of KGs
(Figs 2H–I′, 5D and D′ and 7A and A′). This decrease was
already obvious at E18.5 (Supplementary Material,
Fig. S2I–J′) and correlated with the reduced amounts of (pro)-
filaggrin aggregates seen after immunolabeling (Fig. 7A and
A′) and EM analysis (F in Figs 5D and D′ and 7E and E′).
However, (pro)filaggrin labeling, which normally fades with
cornification, was equally distributed within the entire
mutant SC (Fig. 7A and A′).
Along with cornification, profilaggrin is proteolytically pro-
cessed in its filaggrin units which function in keratin filament
compaction. It is further degraded into free amino acids to
moisturize SC (25). In mutant skin, this processing was
quite insufficient as less monomeric, but much more trimeric
and dimeric filaggrin units were present when compared
with controls (Fig. 7F).
In line with a delay in cornification, the following observa-
tions were made: (i) F-actin persisted in the lower SC layers
(Fig. 6B and B′), (ii) remnant nuclear material was detected
in the first corneocyte layers after hemalaun, terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (TUNEL)
(Supplementary Material, Fig. S4A′ and B′) and 4′,6-diami-
dino-2-phenylindole (DAPI) staining (Fig. 7D′), (iii) these
lower SC layers exhibited residual glycogen (Supplementary
Figure 5. Establishment of a premature LB front. (A and A′) Consecutive skin sections (A1–2 and A′1–2) reveal the front of Ctsd to appear about two layers
earlier in mutants (lower SG) and positive labeling of SC only in control. Asterisks, corresponding hair follicles. (B and B′) In situ transglutaminase activity
exhibits no distinct alterations between mutants and controls. (C and C′) Although the amount of Pex14 labeled peroxisomes is similar, staining intensity is
drastically reduced in mutants. EM analysis reveals the tubulo-vesicular structure of catalase-positive peroxisomes (PO) (CTEM, DAB/OsO4). (A–C
′) Nuclei,
DAPI. (D and E′) EM confirms the front of unreleased LBs in the second SG layer in controls (D) and in the third/fourth SG layer in mutants. (E and E′)
Higher magnifications of indicated frames in (D) and (D′) reveals slightly smaller size of mutant LBs, often containing shortened and fragmented lamellar
stacks (inserts). OsO4/tannin, F, filaggrin-containing F-granule; Lys, lysosome; L, loricrin-containing L-granule; M, mitochondria; V, small clear vesicles.
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Material, Fig. S4C′), restricted to viable layers in controls, and
(iv) degradation of organelle structures within the first three
SC layers was regularly incomplete in mutants (Supplemen-
tary Material, Fig. S4D′).
Late steps in CE assembly are impaired
Sequential CE assembly results in the formation of a highly in-
soluble, protective layer of proteins cross-linked to the keratin
filament–filaggrin complex. Whereas involucrin and transglu-
taminase 1 expression mark early steps in CE assembly, one of
the major CE proteins, loricrin, refers to late scaffold forma-
tion (26). To test whether CerS3 deficiency influences the ex-
pression pattern of early and/or late markers of CE assembly,
we analyzed involucrin and loricrin localization by immunola-
beling.
Involucrin appeared only slightly delayed in mutant SG
(Fig. 7B and B′) and its total protein levels were not altered
Figure 6. Abnormal SC cohesion and persistent periderm. (A and A′) Desmoglein 1/2 (Dsg1/2) reveals CD persistence throughout mutant epidermis, even
without mild alkaline treatment (A′, insert). (B and B′) F-actin intensely decorates lower corneocyte layers only in mutants. F-actin-positive inclusion bodies
delineate the outermost SC layer also in controls (yellow arrows). (C and C′) The distribution of claudin 1 (Cldn1) is similar, but in mutants SC surface is
marked by peridermal TJs (white asterisks). (A–C′) Nuclei, DAPI. (D and D′) Cingulin (Cgn), a TJ-associated protein, exhibits linear strands within control
SG which appear curled in mutants (D′). Yellow asterisk, peridermal nuclear remnant (Draq5). (E and E′) Distribution of desmoplakin 1/2 (Dsp 1/2), a desmo-
somal plaque protein, is not altered. Nuclei, DAPI. (F and F′) EM reveals a typical stratum disjunctum lacking non-peripheral CDs in the control upper SC,
whereas in mutants a periderm persists (red P) equipped with TJs (F′4, red asterisk, kissing points) and desmosomes (F′3-4, red arrows). Cohesion between
upper SC layers is guaranteed by non-peripheral CDs connecting also the periderm (F′1–2, black arrows). Mutant upper corneocytes display trilaminar membrane
structures (F′1, yellow arrows and insert) indicating a phospholipid bilayer. Note the inclusion bodies of the superficial corneocytes in control and mutant. OsO4/
tannin.
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Figure 7. Impaired processing of epidermal proteins. (A and A′) In mutants, (pro)filaggrin (Flg) is weakly expressed within the lower SG, but the CE is intensely
delineated. (B and B′) Involucrin (Ivl) is decreased in mutants. (C and C′) In cryosemithin sections, the increasing loricrin (Lor) signal decorating the rim of
F-granules (white arrows) is obvious, but less intense in mutants. The latter show distinct CE lining. (D and D′) In paraffin sections, a faint loricrin staining
appeared in control stratum disjunctum, but not in stratum compactum (D, insert). After alkaline treatment loricrin labeling strongly increased throughout
SC, including stratum compactum in controls (yellow arrow). Note the reduced expression in mutant SG and the intense nuclear staining in controls (white
arrowheads). White asterisk, residual nuclear DNA. (A–D′) Nuclei, DAPI. (E and E′) EM of the upper SG reveal in mutants a pronounced decrease in both
the size of (pro)filaggrin-containing F-granules (F) and the number of loricrin-containing L-granules (L). The latter occur at the periphery of KGs and
within the nucleus. Yellow asterisks, first corneocyte layer. DAB/OsO4. (F) Immunoblots of the junction proteins desmoglein 1/2 (Dsg 1/2), desmoplakin 1/
2 (Dsp1/2), plakoglobin (Jup), claudin 1 (Cldn1), CE proteins, loricrin (Lor) and involucrin (Ivl) as well as filaggrin (Flg), transglutaminase 1 (Tgm1) and
the endoproteases Ctsd and Klk5. Equal loading was assessed by b-actin. Note, the deficient processing of profilaggrin into filaggrin monomers (1F) via
trimers (3F) and dimers (2F). Blots shown are representative of at least three animals per group.
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(Fig. 7F). Considering the published covalent interactions of
Cers with involucrin (27), we performed in situ methanolic
mild alkaline treatment, but still did not visualize involucrin
in the CE. Besides crosslinking CE proteins, membrane-
anchored Tmg1 may esterify the latter, e.g. involucrin, with
vh-Cers. However, neither Tmg1 protein levels (Fig. 7F) nor
transglutaminase activity in situ (Fig. 5B and B′) was altered.
At the EM level, loricrin granules distributed around the
periphery of F-granules and within nuclei of granular keratino-
cytes. In mutants, their number and size were markedly
reduced in both compartments (Fig. 7E and E′). These obser-
vations were confirmed by WB (Fig. 7F) and immunolabeling.
Strikingly different, an intense loricrin staining was observed
throughout mutant SC distinctly delineating CE (Fig. 7C and
C′). We hypothesized that vh-Cers esterify to loricrin in
control SC to cover the epitope recognized by the antibody.
If so, mild alkaline treatment hydrolyzing ester bonds should
release the epitope in controls for detection of loricrin.
Indeed, loricrin was observed under these conditions in con-
trols in all SC layers and in particular in the SG nuclear com-
partment (Fig. 7D and D′). Hence, CerS3 deficiency impaired
late steps in CE assembly.
We summarized the phenotypic alterations in mutant epi-
dermis and propose a sequence of events in Figure 8.
DISCUSSION
Investigating the recently discovered mammalian CerS family,
we addressed whether a specific CerS is required for
biosynthesis of Cers with ULC-FAs, to which epidermal
vh-Cers belong. Exclusively, CerS2 and CerS3 have been
reported to prefer the longest acyl-CoAs (≤C26) tested in
cell lysates (11,28). Using transfected HeLa cells and mutant
yeast strains, we provide evidence that CerS3 is the only mam-
malian CerS capable of converting ULC-acyl-CoAs into Cers.
In addition, CerS3 uses VLC- and LC-acyl-CoAs, reflecting its
wide substrate specificity. Hence, a combination of CerS3 with
a special acyl-CoA pool is required to explain the unique epi-
dermal Cer pattern observed.
To assess the consequences of CerS3 dysfunction on epider-
mal barrier properties and structure, we eliminated exon 7 in
mice which contains the first conserved amino acids of the
catalytic LAG domain (29). More importantly, exon 7 codes
by computational prediction for a complete transmembrane
domain. Thus, the remaining protein, if expressed, would
have altered membrane topology. This systemic mutation
resulted in complete loss of Cer-based SLs having acyl moi-
eties of 26 or more carbon atoms in epidermis verifying
absence of CerS3 activity and confirming in vivo that CerS3,
but no other CerS, is required for ULC-Cer synthesis. SL de-
ficiency includes those with non-, a- or v-hydroxy-acyl moi-
eties with or without double bonds from D15-position onwards,
pointing out a quite non-specific recognition related to
acyl-CoA modifications. Furthermore, SLs with C22/24-acyl
moieties are significantly reduced, validating in mice CerS3
substrate promiscuity as for acyl-CoA length. As
VLC-acyl-CoAs with C22–C26 are preferred substrates of
CerS2, absence of C26 and reduced C22/C24-SLs in CerS3-
deficient epidermis suggest lack of CerS2 expression in
Figure 8. Schemes of CerS3d/d phenotypic alterations with proposed cascades of events.
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granular and upper spinosum keratinocytes, where we find
CerS3 to be localized in controls. Hence, absence of epidermal
VLC/ULC-SLs results in a lethal WPB breakdown. A similar
WPB disruption leading to murine neonatal death has been
reported for genetic mutations affecting acyl-precursor synthe-
sis, esterification and processing of Cers or intracellular lipid
transport (30–32). In humans, corresponding mutations under-
lie, i.e. severe harlequin ichthyosis, Dorfman–Chanarin syn-
drome, ichthyosis prematurity syndrome and Gaucher
disease (collodion babies) (33–36). Although not mentioned,
published photos of Elov4-, Cgi-58- and ABCA12-deficient
mice suggest also absence of feeding in these strains (37–
39). It may be questioned if neonatal skin barrier disruption
generally alters odor signals responsible for maternal recogni-
tion and nursing (40–42).
Using cultured neonatal skin inoculated with C. albicans, we
demonstrated that the loss of VLC/ULC-SL compromises the
cutaneous barrier against pathogens. Rather than altered anti-
microbial peptides, the following factors may facilitate C. albi-
cans invasion: (i) increased water flux across the deficient WPB
enhancing SC hydration, (ii) impaired keratin filament compac-
tion through insufficient filaggrin processing likely accelerating
proteolysis for penetration, (iii) residual periderm improving
adhesiveness, and (iv) loss of Cer downstream products per
se possessing potent antimicrobial properties. Indeed, the bio-
active SLs, sphingosine and phytosphingosine generated from
Cers during final cornification are natural antimicrobial
agents, preventing Staphylococcus aureus infection or growth
of C. albicans (4,5,7). In CerS3-deficient epidermis, Cers are
basically absent and sphingosine levels drop to very low
levels. Our data underscore a dual, indispensable function of
Cers in skin. They serve as mortar in WPB maintenance and
as a superficial coat for anti-microbial defense, the latter via
sphingosine.
The structural basis for barrier disruption can be clearly
attributed to the presence of ELL-free intercellular domains
already occurring at the interface and throughout SC. Thus,
sealing of the extracellular space is strikingly insufficient
and ELL-free domains may operate like pores of a sieve me-
diating excess paracellular water and electrolyte loss, thereby
disrupting the highly regulated pH and/or Ca2+ gradient across
SC. It may be noted that ULC-Cers, completely missing in
mutants, apparently are not a prerequisite of ELL formation, al-
though the ordered structures are restricted to specific domains
between the lower two to three SC layers. However, in upper
SC the residual, incomplete lipid mixture, basically composed
of cholesterol and free FAs, is compacted to focal agglomerates
indicating impaired CLE formation. One could speculate that
the absence of protein-bound Cers at the CE surface is the
driving force of lipid cluster formation. Increased hydrophilic
surface properties of opposing corneocytes due to insufficient
CLE formation may favor their approximation pushing remain-
ing extracellular lipids to fuse into agglomerates. Hence, an
intact CLE would serve as ‘chaperone’ for even spreading of
ELL and/or as cohesion/stabilizer of ELL. Our findings under-
score the essential role of VLC/ULC-Cers in proper CLE for-
mation required for organization and maturation of the
extracellular lipid system. Consequently, a decrease in the
total Cer content necessarily results in diminished barrier func-
tion as seen in many human skin disorders (2,43–45).
Although protein-bound vh-Cers were missing in mutants,
an electron-dense CE beneath the plasma membrane appears
unaltered ultrastructurally. Following the labeling of loricrin,
a major CE compound comprising up to 85% of the CE pro-
teins (46), we document loss of ULC-Cers to be responsible
for unmasking of loricrin throughout the mutant SC. Like
involucrin, loricrin is not recognized within control SC by
most antibodies due to posttranslational processing (47,48).
As we could release the hidden loricrin epitope in control
CE upon alkaline treatment, but did not uncover involucrin,
it appears plausible that the epitope recognized in loricrin is
an esterification site for vh-Cers but not for other CE proteins.
This suggests an important role in CLE formation for loricrin,
a late component in CE assembly. It offers a suitable tool to
unveil abnormalities of the cutaneous extracellular lipid
system on sections from patients with skin disorders.
Unravelling the effects of vh-Cer deficiency on epidermal
morphology in more detail, we demonstrate further conspicu-
ous phenotypic alterations including accelerated LB formation
and release, hyperkeratosis, abnormal SC cohesion, mainten-
ance of the trilaminar plasma membrane structure of corneo-
cytes and persistent periderm, all of which reflect impaired
cornification.
Regarding the LB secretory system in mutants, we docu-
mented a conspicuous shift of the LB front one to two cell
layers earlier which may result from increased water flux.
The latter destroys the epidermal calcium gradient triggering
accelerated LB synthesis and extrusion (17). This in turn
leads apparently to incomplete packing of other target compo-
nents, such as Ctsd which exhibits a drastic decrease in SG la-
beling intensity and is nearly absent in SC.
Although LB formation and secretion appear accelerated,
we observed a general maturation delay of corneocytes. In
line with this delay, profilaggrin-containing KGs display a
small, immature size even in the uppermost SG layer and pro-
cessing of profilaggrin into monomers is retarded as residual
monomers/multimers are easily recognizable in mutant SC.
Before being proteolytically degraded into individual amino
acids, profilaggrin is cleaved into filaggrin monomers. They
crosslink keratin filaments to each other and to the CE, a
process required for keratin filament bundling and compaction
(25). Lower monomer levels thus will hinder condensation of
corneocytes as observed throughout mutant SC.
A processing defect of profilaggrin into filaggrin monomers
has been described in mice and humans with mutations in the
filaggrin gene being associated, i.e. with atopic dermatitis (49).
Here, we show delayed filaggrin processing may not necessar-
ily result from filaggrin gene mutations, but may derive from
lipid barrier abnormalities.
Further evidence for deficient cornification is reflected by
persistence of corneocyte trilaminar plasma membrane struc-
tures and non-peripheral CDs. The latter are not only seen in
stratum compactum like in controls, but up to the top of
mutant SC, and hinder transition of stratum compactum into
stratum disjunctum. Although plaque proteins, e.g. desmopla-
kin 1/2 likely, are degraded in control and mutant SC, the
cytosolic domain of desmoglein 1 is preserved throughout
mutant, but not control SC. This is in line with deficient extra-
cellular processing of the desmosomal core containing the
extracellular domains of desmoglein 1. CD retention may be
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attributed to lowered protease activities arising from increased
pH and inadequate protease secretion. Here, we show reduced
Ctsd labeling of SC. Ctsd is involved in CD degradation (21)
and requires an acidic pH for optimal activity (50). Skin hy-
dration directly regulates SC pH. Disruption of the WPB
leads to increased release of interstitial fluid with a neutral
pH counteracting acidification of the skin. Additionally, the
increased pH may be attributed to decreased histidine-to-
urocanic-acid generation as a matter of insufficient filaggrin
breakdown (22) and/or dysfunction of secretory phospholipase
A2 generating free FAs as well as decreased activity of the
sodium-proton exchanger, type 1 (NHE1) (51). Increased SC
pH in turn may also contribute to a residual phospholipid
bilayer due to lowered lipase activities. Interestingly, CD per-
sistence is also a characteristic feature of ichthyosis and
xerosis combined with hyperkeratosis (52).
Cohesive CDs may also be responsible for postnatal persist-
ence of periderm and maintenance of its intercellular junctions
(desmosomes and TJs). This embryonic structure shed before
birth in controls is very sensitive to mechanical stress and
therefore easily detached, leaving traces of cell debris.
Indeed, residual nuclear DNA on top of SC is described in
Abca12-deficient mice, but discussed as parakeratosis (53).
However, nuclear staining within SC is not detectable. These
topical nuclear remnants may derive alternatively from re-
sidual periderm. It is questionable whether a persisting, but
not recognized periderm exists in published mouse models
presenting similar barrier defect and morphological pheno-
type, e.g. as documented for Elovl4-deficient mice in
Figure 4B (54).
In conclusion, CerS3 is essential for the synthesis of CLE-
and ELL-Cers and importantly for Cer-derived sphingosines.
Hence, CerS3 determines the quality of WPB and anti-
microbial function as well as final cornification. Currently,
no monogenetic human skin disease associated with CERS3
has been identified. As mutations may lead to impaired
barrier function irreplaceable by other CerS, the phenotype
expected may be related to atopic dermatitis, ichthyosis or
psoriasis. Paradigmatically, in a large cohort of families
affected by autosomal recessive congenital ichthyosis, 78%
of all cases could be linked to established gene mutations,
i.e. in FLG, ABCA12 or TGM1. For 22%, the affected gene
remained to be identified. Interestingly, mutations in 12 of at
least 34 genes directly affect lipid metabolism (55). In add-
ition, considering sphingosine as an important component of
the antimicrobial barrier and innate skin immunity, i.e.
chronic mucocutaneous candidiasis disease, for which in
most cases the underlying etiology is still unknown (56,57),
offers a potential linkage to the CERS3 gene. As CMC repre-
sents a prominent feature in severe atopic dermatitis (58) asso-
ciated with 2-fold reduction in SC sphingosines (4) screening
for mutations of CERS3 in affected families may be consid-
ered. Finally, the important role of SLs in atopic dermatitis
had been underlined by the beneficial topical application of
a ceramide-dominant mixture as exemplified in reference
(59), which independently of the utilized ceramide species
should release antimicrobial sphingosine.
MATERIALS AND METHODS
Generation of CerS3 and CerS2 expression plasmids
Mammalian expression plasmids encoding for either human
CerS2 or mouse CerS3 were generated by cloning of Cers2
(officially longevity assurance homolog 2, Lass2) or Cers3
(Lass3) cDNA into the N-terminus of an EGFP taq vector.
Thus, cDNA isolated from the kidney (for CerS2) and testis
(for CerS3) was amplified by PCR using specific primers
(see Table 1 for primer sequences and temperature condi-
tions). For CerS3, a DNA fragment including exons 2–11
but excluding exon 1, which is absent in the human protein,
was used for cloning. The amplified DNA fragments were
then inserted into pEGFP-N1 (Clonetech) vector by HindIII/
EcoRI or EcoRI/BamHI sites for CerS2 and CerS3, respective-
ly. Following DNA digestion of the corresponding inserts and
Table 1. Primers used for the generation of expression constructs





mCerS3-EGFP Fb 5′-ATG TTT CAG ACG TTT AGA AAA TGG TT-3′ 56, 56 1171
Rb 5′-CGC CAC ATT GTG CTT CAA-3′
F 5′-TAT ATA GAA TTC GCC ACC ATG TTT CAG ACG TTT AGA AAA TGG TTC
TGG-3′
56, 62 1181
R 5 ′-TAT ATA GGA TCC GTA CGG CCA TGC TGA CCA TTG GCA ATG-3′
hCerS2-EGFP F 5′-CAG GAT GCT CCA GAC CTT GT-3′ 53, 53 1164
R 5′-GCA GCT GGA ATA ATG GTT CA-3′
F 5′-TAT ATA AAG CTT GCC ACC ATG CTC CAG ACC TTG TAT GAT TAC TT-3′ 54, 62 1171
R 5′-TAT ATA GAA TTC GGT CAT TCT TAC GAT GGT TGT TAT TGA GGA TG-3′
pRevTRE2-mCerS3-EGFP F 5′-TAT ATA GGA TCC GC CAC CAT GTT TCA GAC GTT TAG AAA ATG GTT CTG
G-3′
56, 66 1181
R 5′-TAT ATA ACC GGT GTA CGG CCA TGC TGA CCA TTG GCA ATG-3′
pRevTRE2-hCerS3-EGFP F 5′-TAT ATA GGA TCC GCC ACC ATG TTT TGG ACG TTT AAA GAA TGG TTC
TGG-3′
56, 66 1181
R 5′-TAT ATA ACC GGT GTA TGG CCA TGC TGG CCA TTG GGA ATG-3′
Restriction sites are underlined.
aT1 corresponds to the annealing temperature used for the first 10 cyles, T2 corresponds to the annealing temperature used for the following 15 cycles.
bF, forward primer; R, reverse primer.
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vectors, these were subsequently ligated to generate
hCerS2-EGFP and mCerS3-EGFP.
For retroviral transduction, mCerS3-EGFP and human
CerS3 plasmids (EX-T7111-M02, Genecopoeia) were further
subcloned into pRevTRE2-EGFP. Both genes were inserted
using primers flanked with BamHI and AgeI sites.
All PCR products were generated using Pfu polymerase
(Promega). The sequences of all constructs were verified by
DNA sequencing.
Generation of stable cell lines expressing CerS3
Stable cell lines expressing CerS3-EGFP (mouse and human),
as well as EGFP (control), were generated by retroviral trans-
duction using genetically modified HeLa cells
(HeLamCAT1-rtTA2-M2). Previous integration of mCAT1
(murine cationic amino acid transporter 1) and the doxycyc-
line-sensitive transactivator rtTA2-M2 (optimized reverse
tetracycline-controlled transactivator) allowed the generation
of inducible HeLa cells expressing the gene of interest, as
already described (60). Briefly, viral particles required for
transduction were produced in the capsid-forming cell line
HEK-293T. These virions were generated via the triple trans-
fection with (i) a MoMLV (Moloney murine leukemia virus)
derived retroviral vector encoding CerS3 from the doxycyc-
line/transactivator responsive element (pRevTRE2-CerS3-
EGFP or control pRevTRE2-EGFP), together with (ii)
gag-pol (pVPack-GP) and (iii) envelope (pVPack-Eco). The
latter vectors are both responsible for the formation of viral
proteins. MBS mammalian transfection kit and pVPack
vectors were used according to the manufacturer’s recommen-
dations (Stratagene). Following 48 h transfection, virions were
collected and used to transduce target cells. After 40 h incuba-
tion with 2 mg/ml doxycycline, fluorescent-positive cells were
isolated by fluorescence-activated cell sorting. These popula-
tions were cultured for 7 days in the absence of doxycycline
and then selected for negative fluorescence signals. Following
an additional 7 days induction with doxycyline, single cell
clones were sorted by EGFP-derived fluorescence. HeLa cell
lines expressing mCerS3-EGFP, hCerS3-EGFP and control
EGFP were generated according to this procedure.
Chemical synthesis
Montanoyl(C28:0)-CoA. For activation of the carboxylic acid,
montanic acid (28:0, 100 mmol, Sigma) was dissolved in tetra-
hydrofuran (4 ml, Fluka). Equimolar amounts of
N-hydroxysuccinimide (Fluka) and dicyclohexylcarbodiimide
(Fluka) were added at room temperature (RT) and the reaction
was kept under nitrogen for 12 h. The activated FAs were
coupled to the polysilylated form of coenzyme A, which
was generated in situ as previously described with slight mod-
ifications (61). Thus, the trilithium salt of coenzyme A
(American Radiolabeled Chemicals) was passed through a
Dowex-50 ion exchange column acidified with 1 M HCl and
subsequently lyophilized. The resulting free CoA (26 mmol)
was dissolved in dry acetonitrile (2 ml, Fluka). Dimethylke-
tene methyl trimethylsilyl acetal (650 mmol, Sigma) was
added and the resulting solution was stirred for 16 h under ni-
trogen. After removal of all volatiles using a nitrogen stream,
the polysilylated coenzyme A was dissolved in 1 ml of dry
tetrahydrofuran. To a stirred solution of activated FA
(39 mmol) in tetrahydrofuran containing CsF (1.3 mmol,
Fluka) and dicyclohexano-18-crown-6 (0.13 mmol, Fluka),
the coenzyme A solution was added drop-wise and the reac-
tion mixture was stirred for 4 h at RT. The crude mixture
was acidified with an equal volume of 10 mM KH2PO4 (pH
5.5), and the organic solvent was removed using a nitrogen
stream. The aqueous phase was desalted using a reverse
phase C18 column and the final product was eluted with
methanol. For quantification, MS analyses with acyl-CoAs
of known concentrations were performed.
Ceramide internal standards for electrospray-ionization
tandem-MS. FAs were activated into their respective
N-hydroxysuccinimide esters as reported above, and then con-
densed (40 mmol each) with d17:1-sphingosine (10.5 mmol,
Avanti Polar Lipids) in a final volume of 4 ml tetrahydrofuran.
The reaction was catalyzed by triethylamine (Sigma) for 1–2
days at RT in an inert atmosphere. The crude products were
purified by silica gel flash-column chromatography using mix-
tures of hexane/isopropanol/water of increased polarity as
solvent system. For quantification, a dilution series of the puri-
fied products were spotted on a high-performance TLC
(HPTLC) together with standards of known concentration
and separated with the cloroform/methanol/acetic acid (188/
11/1). After development with 10% copper (II) sulphate in
8% sulphuric acid (10 min at 1808C), quantification of the
bands was performed by densitrometric scanning using a
TLC scanner (Shimadzu CS-9301).
ULC-CoA specificity assay of CerS2 and CerS3
Living mammalian cells. HeLa cells stably transfected with
mouse and human CerS3, EGFP control, as well as untreated
cells (HeLamCAT1-rtTA2-M2) were seeded onto six-well plates
with a density of 1 × 105 cells/well with or without induction
with 2 mg/ml doxycycline. Forty-eight hours after seeding, un-
treated cells were transfected with hCerS2-EGFP and incu-
bated for 4 h at 378C. The assay was started by exposing the
cells to media containing a mixture of saturated acyl-CoAs,
namely C16:0, C18:0, C24:0, C26:0 (Avanti Polar Lipids)
and C28:0 (10 mM each) and 6 mM sphingosine (d17:1).
Upon 20 h of reaction, cells were harvested and lipids
extracted. Uptake only occurred in the presence of the crude
montanoyl CoA (as described), with no incorporation using
HPLC-MS purified C28:0-CoA.
Yeast. The strains used for this assay were the following:
RH2888 (MATa his3 leu2 lys2 trp1 ura3 can1 bar1),
RH6974 (MATa FLAG-MmCerS2::TRP1 lac1D::ADE2
lag1D::HIS3 leu2 ura3 lys2 can1 bar1) and RH6975 (MATa
FLAG-HsCerS3::TRP1 lac1D::ADE2 lag1D::HIS3 leu2 ura3
lys2 can1 bar1). All mutations were constructed using stand-
ard gene disruption procedures, with complete removal of
open reading frames in the RH2888 strain background.
Double and triple mutants were obtained by genetic crosses.
Synthetic N-terminally FLAG-tagged (FLAG-tag sequence:
N-DYKDDDDK-C) open reading frames corresponding to
mouse CerS2 and human CerS3 were purchased from
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GeneArt (Germany) as yeast codon optimized open reading
frames, subcloned for expression under control of a TDH3 pro-
moter and inserted into the genome to construct stable cell
lines. Sequences are available upon request.
For CerS assay in vivo, hCerS3 and mCerS2 expressing
strains deleted for the yeast ceramide synthases, LAC1 and
LAG1, and control yeast strains were transformed with the
wild-type or mutated Sur4 protein (F262A/K266L, kind gift
from J. Weissman) (14). Yeast was grown on SD medium
with the required nutrients to a final concentration of 1
OD600/ml and lipids were extracted from 50 ml of cells as
described below.
Generation of CerS3d/d mice
The Cers3 gene (ceramide synthase 3, Lass3, NCBI gene ID:
545975) was found in a mouse C57Bl6 bacterial artificial
chromosome (BAC) Library (RPCI-23 No. 731, German Re-
source Center for Genome Research, RZPD). From the corre-
sponding BAC-DNA clone, a 10 kb XbaI/XhoI fragment
including exons 5–9 of Cers3 was subcloned into a pBlue-
script plasmid vector (Stratagene). An HSVtk-PGKneo cas-
sette flanked by two FRT, one 5′-single loxP side and a
diagnostic SacI side was cloned into ClaI in introns 6–7. A
single loxP site was inserted into SpeI of introns 7–8. A
PGK-DTA cassette was inserted into XhoI at the 3′ end of
the targeting construct. E14 ES cells derived from mouse
strain 129 SV Ola were transfected in the presence of the lin-
earized Cers3-targeting vector. Stem cell clones were picked,
expanded and checked for homologous recombination of
Cers3 by Southern blot analysis. Genomic ES-cell DNA was
digested with SacI and a digoxigenin labeled 3′-outside
probe (Roche) was used to stain wild-type and mutant
alleles. No positive clone could be detected out of 384 culti-
vated. Sequence analysis of the C57Bl6 mouse line-derived
targeting vector DNA resulted into pronounced variations in
particular within intron 5 of the 5′ region of the targeting con-
struct when compared with 129 SV Ola DNA from which
mouse strain stem cells were derived. Therefore, the 5′ arm
of the targeting construct was replaced by a PCR product
amplified with a proofreading polymerase from a genomic
129 SV Ola DNA. Sequence analysis of the changed targeting
construct showed a correct Cers3 sequence for all exons, in-
cluding the 129 SV Ola derived 5′-arm. As verified by South-
ern blot analysis, electroporation with the reconstructed vector
resulted in two clones out of 384 with correct 5′ insertion of the
targeting construct, including the selection cassette with 5′ loxP
side. Only one of the respective ES clones showed an integra-
tion of the single loxP site 3′ from exon 7. Stem cells from the
latter clone were expanded and injected into blastocysts. Germ-
line transmission of mutant stem cells was achieved, indicated
by agouti colored offspring from chimeras. F1 offspring with
loxP-flanked exon 7 were further mated with cre-deleter mice
to obtain a systemic deletion of exon 7 of the Cers3 gene. In
the next breeding step, the cre-transgene was again removed
by mating with C57Bl6 wild-type mice. Heterozygous mice
were mated in order to generate homozygous offspring with
complete exon 7 deletion in Cers3 in both alleles.
All animal procedures were approved and performed in ac-
cordance with federal laws (Regierungspra¨sidium Karlsruhe,
Germany, G-68/07, G-8/07 and A-62/06).
Genotyping of mutant mice
ES cells, F1 offspring and mutant mice were genotyped by
Southern blot and PCR analyses. The 3′ and 5′ Southern
probes were synthesized using the PCR DIG probe synthesis
kit, essentially according to the manufacturers protocol
(Roche). For PCR analyses, either genomic DNA isolated
from mice tails or cDNA isolated from skin were used as tem-
plates to amplify specific products for wild-type and mutant
alleles. Primers used to perform these analyses including the
corresponding conditions are specified in Table 2. The gener-
ation of the truncated Cers3 transcript lacking exon 7 in
mutant mice was confirmed by DNA sequencing.
RNA isolation and quantitative real-time PCR
Neonatal CerS3d/d and littermate control skin was collected to
compare relative mRNA expression levels of CerS
Table 2. Primers used for the generation and genotyping of CerS3d/d mice
Gene Primer sequence Ta (8C) Product size (bp)
Primers used for Southern blot
5′ probe F 5′-TGA CAA CCC CAC TGC AAA ACT-3′ 58 557
R 5′-ATC CCA GCT TGT GGA TGG ATT-3′
3′ probe F 5′-AAT GAA TGC TTC TGC CTT TCC A-3′ 58 506
R 5′-TGG GAG AGG AGC CTC ACT ACA G-3′
Primers used for genomic DNA genotyping
CerS3Dexon7 F 5′-ACA TAT CTC CCT TTG CCC TGA TG-3′ 58 1004a, 272b
R 5′-GAC AGC CCT GAA ATG TAT CAT GC-3′
Primers used for cDNA genotyping
CerS3-ex6-11 F 5′-TCT GGG AGG TTT GGA ATG AC-3′ 55 687a, 594b
R 5′-CGC CAC ATT GTG CTT CAA-3′
Primers used for quantitative RT–PCR
RT-CerS3Dex7 F 5′- GGT CAC TGG TGT TTA GCC TGA-3′ 55 128
R 5′-GGT CCC ACT GCG AAT GTA AT-3′
aProduct size for wild-type CerS3 allele.
bProduct size for mutant CerS3 allele.
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homologues and antimicrobial peptides. Total RNA was
extracted using Trizol reagent (Invitrogen) according to the
manufacturer’s instructions, following integrity assessment
using RNA6000 Nanochip (Agilent). Double-stranded cDNA
was synthesized and evaluated for relative gene expression
as previously described (13). Results represent the fold-change
of expression calculated using the comparative Ct method.
Normalized DCt values were compared with normalized DCt
of wild-type mCers5- and mCamp-mRNA for quantification
of Cers- and antimicrobial peptide-mRNAs, respectively.
Primers used for enhancing specifically each Cers homologue
were as reported (13), with the exception of Cers3, where
primers within exons 7 and 8 were used and are indicated in
Table 2. Primers used for quantitative reverse transcription
polymerase chain reaction (qRT–PCR) of antimicrobial pep-
tides and the corresponding specific conditions are detailed
in Table 3.
Skin permeability assay
Skin permeability was tested by diffusion using Mayer’s
hemalaun essentially as described (38). In brief, euthanized
embryos and newborn animals were fixed in methanol for
5 min, washed with phosphate-buffered saline (PBS) and incu-
bated in Mayer’s hemalaun (Roth) for 20–30 min at RT.
Excess hemalaun was removed by several thorough washes
with PBS. After hemalaun staining, images of the animals
were captured using a digital camera.
Determination of TEWL and epidermal pH
TEWL was measured using a Tewameter TM300 (Courage-
Khazaka Electronics) as described (48).
Preliminary skin surface pH measurements were performed
using humidified pH-indicator strips (pH 5.2–7.2, Merck).
Candida albicans infection of cultured skin samples
Interscapular skin samples of newborns were maintained
viable on collagen gels partially submerged in the Dulbecco’s
modified Eagle’s medium (DMEM) (Lonza, BE12-604F)
supplemented with 50 U/ml penicillin and 50 mg/ml strepto-
mycin (Gibco). Collagen gels were prepared as previously
described (62). Thus, type I collagen was isolated from tail
tendons of young rats and lyophilized. To a 4 mg/ml solution
of collagen in 0.1% acetic acid was added 10% of 10× Hank’s
balanced salt solution (Gibco) titrated with 5 M sodium
hydroxide and 10% of the DMEM medium. The mixture
was allowed to jellify in PET membrane filter inserts
(Falcon) for 1 h at 378C, following the addition of 12 ml
DMEM medium in each of the deep-wells (BD Biosciences,
BD 355467).
Candida albicans (ATCC 90028) grown overnight in the
LB medium were harvested and resuspended in PBS to a con-
centration of 109/ml. Candida albicans (1 × 106 cells, 1 ml)
were inoculated to the center of the skin sample and incubated
at 308C for the specified time.
For quantification of microbial growth, infected skin
samples from E18.5+ 0.5 mice were flushed with 10 ml
PBS. An aliquot of these suspensions (100 ml) were plated
in two different dilutions on Sabouroud agar plates (bioMe´r-
ieux). Multiple serial dilutions had been previously performed
to determine optimal conditions. After 24 h incubation at
378C, colonies were counted and concentrations were deter-
mined as colony forming units (CFU/ml).
Lipid extraction
For the extraction of epidermal lipids, interscapular skin
samples were rapidly dissected and snap-frozen in liquid nitro-
gen. To separate epidermis from dermis, samples were treated
with 500 mg/ml thermolysin buffer (containing 10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
142 mM NaCl, 6.7 mM KCl, 0.43 mM NaOH, 1 mM CaCl2 at
pH 7.4) for 2 h at 378C (63). Isolated epidermis was then
cut into small pieces and lyophilized. SLs were extracted
according to Doering et al. with slight modifications (48,64).
In brief, 3 mg of dry weight epidermis was extracted with
2 ml of chloroform/methanol/distilled water 30/60/8 by
volume at 508C for 15 min under sonication. Supernatant
was taken after centrifugation and pellets were re-extracted
two additional times using the solvent mixtures of chloro-
form/methanol/distilled water, 10/10/1, and chloroform/
methanol, 2:1 by volume. Supernatants were pooled and
desalted using reversed phase RP-18 columns. For further ana-
lysis, aliquots of the extract pool were saponified under mild
alkaline conditions (0.1 M methanolic KOH, 4 h, 508C), neu-
tralized with acetic acid and desalted using 100 mg-RP-18
Table 3. Primers used for qRT–PCR of antimicrobial peptides
Gene Primer sequence T (8C) Product size (bp)
mBD1/Defb1 F 5′-GGT GTT GGC ATT CTC ACA AGT C-3′ 60 99
R 5′-GGT ATT AGA TGG GCA GCT GGA G-3′
mBD2/Defb2 F 5′-TGC TGC CTC CTT TTC TCA TAT ACC A-3′ 60 78
R 5′-GTG GTC AAG TTC TGC TTC GTA TC-3′
mBD3/Defb3 F 5′-ATG CTG GAA TCG GTG CAT TGG CA-3′ 64 138
R 5′-CTT CAT GGA GGA GCA AAT TCT GGT GT-3′
mBD4a/Defb4 F 5′-CAC ATT TCT CCT GGT GCT GCT-3′ 64 52
R 5′-GAT AAT TTG GGT AAA GGC TGC AA-3′
mCamp F 5′-CTT CAA CCA GCA GTC CCT AGA CA-3′ 60 53
R 5′-GAT CCA GGT CCA GGA GAC GGT A-3′
aBD4 primer sequence reported by Dorschner et al. (76).
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columns. Protein-bound SLs were extracted from the above
obtained pellets. Pellets were ‘washed’ three times with 2 ml
of 100% methanol for 5 min and two times with 2 ml of
95% methanol at 608C for 2 h to remove residual-free lipids.
Treatment of the residual pellets with 1 ml of 1 M KOH in
95% methanol at 608C for 2 h cleaved ester linkages and
released protein-bound SLs. Supernatants were neutralized
with acetic acid and desalted using RP-18 columns as above.
For the extraction of SLs from HeLa cells, dried cell pellets
were extracted twice with 2 ml of chloroform/methanol/dis-
tilled water, 10/10/1 and once with 30/60/8 (by vol.) for
15 min at 378C. Combined lipid extracts were subjected to
methanolic mild alkaline hydrolysis for 2 h at 378C, sequen-
tially neutralized and desalted.
For the extraction of yeast lipids, internal standards were
added to the samples (10 mg each of Cer (d18:1,17:0) and
GlcCer (d18:1, 8:0), Avanti Polar Lipids), which were then
extracted using an ethanol-ether-based solvent and base
treated with monomethylamine as described (65). Lipids
were desalted with butanol and analyzed by MS.
Lipid analyses
Lipids isolated from epidermal extracts were first analyzed by
TLC. Lipids corresponding to 0.5 mg dry weight were spotted
on HPTLC plates (Silicagel 60 F254, Merck) using a Linomat
IV (Camag). Afterwards, lipids were separated sequentially
with the following solvent systems: (i) chloroform/acetone
(1/1) for 4 cm, (ii) chloroform/methanol/glacial acetic acid
(60/35/8) for 7 cm, (iii) chloroform/methanol/glacial acetic
acid (190/9/1) for 12 cm, and (iv) n-hexane/methyl t-butyl
ether/glacial acetic acid (90/10/1) until the top (20 cm). In
between the different solvent systems, plates were thoroughly
dried under vacuum. Bands were then made visible by spray-
ing the TLC plates in 10% copper sulphate in 8% sulphuric
acid and developing at 1808C.
Quantification of SLs was performed by tandem MS (triple
quadrupole instrument equipped with a nano-electrospray
source, VG micromass model Quattro II, Waters) according
to reference (48). Equivalent lipid samples regarding the
protein content were dissolved in 5 mM ammonium acetate
in methanol. Prior to being analyzed, internal standards were
added to the aliquots. Linoleic acid-esterified vh-SLs were
determined by subtraction of the amount of free vh-SLs of
the non-treated epidermal extracts from the respective
amounts of vh-SLs evaluated after saponification.
Epidermal sphingosine levels were quantified with a novel
assay based on derivation of sphingosine prior to tandem
MS (unpublished data).
For the quantification of yeast extracts, lipids were intro-
duced into a Varian 320MS triple quadrupole in LC mode
by direct infusion in methanol/chloroform/water (7/2/1, con-
taining 2 mM ammonium acetate) (66). To quantify lipid
species, multiple ion monitoring was used for each species
(65). The recoveries and amounts of different IPC species
were calculated relative to the GlcCer (d18:1, 8:0) standard
according to a standard curve. Results are presented as a per-
centage of total IPCs detected because absolute amounts could
not be determined without internal standards.
Epidermal protein isolation and western blotting
Skin samples were incubated at 588C for 6 min in PBS con-
taining 10 mM ethylenediaminetetraacetic acid (EDTA) in
order to separate dermis from epidermis. Skin was then trans-
ferred into ice-cold PBS-EDTA solution and epidermis was
obtained by peeling off the dermis. Epidermis in digitonin
lysis buffer [20 mM HEPES-NaOH buffer (pH 7.4) containing
25 mM KCl, 250 mM sucrose, 2 mM MgCl2, with freshly added
1% digitonin (Sigma), complete protease inhibitors (Roche)
and 0.5 mM DTT] was homogenized by sonication (Branson
sonifier 250) using five pulses every 30 s for 5 min. Lysates
containing epidermal proteins were cleared by centrifugation
at 21 000g for 15 min. Equal amounts of protein (50 mg)
were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, blotted onto nitrocellulose membranes,
incubated with primary antibodies overnight at 48C and sec-
ondary antibody for 45–60 min at RT (details in Tables 4
and 5).
Light and electron microscopy
All morphological data included a minimum of two animals
per group. Mouse embryos (E18.5) and newborns were
anesthetized and transcardially perfused for 5–10 min with
3.5–4% glutaraldehyde in 0.1 M sodium cacodylate buffer
(pH 7.6) containing saturated picric acid (300 ml per 100 ml
fixative solution), 2% polyvinylpyrrolidone (PVP, Polyvidon
25, MW 25000, Merck) and 0.05% CaCl2. Interscapular skin
samples were removed and additionally postfixed overnight
in the same fixative. In order to preserve the periderm and
the adherent SC layers, samples were embedded in agar
(Extrapure, Merck). Sections of 80–150 mm thickness were
prepared using a microslicer (Dosaka DTK 1000). Sample pro-
cessing followed three different procedures tested for optimal
visualization of LB and ELL structure as well as keratinocyte
morphology. Following the protocol of reference (67), the first
series were treated with 0.25% RuO4 (Polysciences) in 0.1 M
sodium cacodylate buffer, pH 6.8 containing 0.5% potassium
ferrocyanide for 15 min (Supplementary Material,
Fig. S3A1). The second series was postfixed according to ref-
erence (68) with 1% buffered OsO4 in 0.1 M sodium cacody-
late buffer, pH 7.6 for 90 min, followed by treatment with
1% tannic acid (Merck) in 0.5 M sodium cacodylate buffer,
pH 7.5 for 10 min. Sections were immersed in the same
buffer containing 1% Na2SO4 for 90 s (Supplementary Mater-
ial, Fig. S3A2). As described (69), the third series was incu-
bated 60 min in alkaline DAB for selective catalase
visualization and enhancement of membrane staining. Sec-
tions were postfixed with 1.5% buffered OsO4 in sodium caco-
dylate buffer, pH 7.6 containing 1.5% potassium ferrocyanide
for 20–30 min, followed then by osmification without ferro-
cyanide for an additional 40–60 min. En bloc staining was
performed with 1% uranyl acetate for 20–30 min (Supplemen-
tary Material, Fig. S3A3). Samples of all three series were
washed with the respective buffers and processed for embed-
ding in Epon 812.
Fixed on Superfrostw slides, serial semithin sections of 0.5–
1 mm thickness were prepared (LeicaUltracut UCT) and stained
with periodic acid-Schiff (PAS) as described (70). Briefly, Epon
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sections were immersed in a freshly prepared 5% periodic acid
solution at 608C for 2 × 30 min, rinsed in distilled H2O for
30 min and dried at 858C. Sections were then incubated with
Schiff solution for 90 min (2 × 45 min) at 608C, with an add-
itional rinsing and drying step. Subsequently, samples were
counterstained with a modified Richardson solution containing
Table 4. Primary antibodies used for immunofluorescence and immunoblots
Antibody Gene name Host/ligand—
clonalitya
Applicationb Dilution Supplier (clone) Order num.
b-Actin Actb Rabbit—p WB 1:1000 Santa Cruz sc-1616-R
F-Actin – TRITC-phalloidin Cryo SM 1:600 Sigma P1951






Rabbit—p Paraffin 1:1000 PickCell Laboratories Custom-madec
Cholesterol – Filipin Unfix. cryo 10 mg/ml Sigma F9765
Cingulin Cgn Guinea Unfix. cryo 1:2000 Provided by L. Langbein –
Pig—p
Claudin1 Cldn1 Rabbit—p WB 1:100 Thermo Scientific RB-9209
Unfix. cryo 1:10
Dansyld – Rabbit—p Unfix. cryo 1:100 Invitrogen A6398









(Pro)Filaggrin Flg Rabbit—p WB 1:1000 Covance PRB-417P
Paraffin 1:50
GFP Gfp Rabbit—p WB 1:1000 Genetex GTX26556
Golgin-97 (Golgin A1) Golga1 Mouse—m ICC 1:200 Molecular Probes A-21270
Involucrin Ivl Rabbit—p WB 1:100 Thermo Scientific RB-10288
Cryo SM 1:150 Covance PRB-140C
Paraffin 1:100
Kalilkrein 5 Klk5 Rabbit—p WB 1:100 Abgent AP6324b
Keratin 10 Krt10 Guinea Unfix. cryo 1:5000 Provided by L. Langbein –
Pig—p
Keratin 14 Krt14 Guinea Unfix. cryo 1:3000 Provided by L. Langbein –
Pig—p
Ki67 MKi67 Rat—m Paraffin 1:200 Dako (TEC-3) M7249
Lysosomal-associated membr. prot. 1 Lamp1 Rabbit—p ICC 1:200 Acris SP5446P
Loricrin Lor Rabbit—p WB 1:1000 Covance PRB-145P
Cryo SM 1:150
Paraffin 1:100
Polar and neutral lipids – Nile red Unfix. cryo 5 mg/ml MP Biomedicals 151744
Protein disulphide isomerase Pdi Mouse—m ICC 1:400 Acris SM5075
Peroxisomal biogenesis factor 14 Pex14 Rabbit—p Unfix. cryo 1:100 Protein Tech Group 10594-1-AP
Plakoglobin Jup Mouse—m WB 1:200 Provided by H. Heid (Progen, PG
5.1)
65105
Transgluta-minase 1 Tgm1 Rabbit—p WB 1:4000 Abcam ab86589
am, monoclonal; p, polyclonal.
bCryo SM: ultracryosemithin sections; ICC: immunocytochemistry of HeLa cells; Paraffin: paraffin sections; Unfix. cryo: unfixed cryo-sections; WB: western blot.
cCustom-made against a peptide located at the C-terminus of the mouse CerS3.
dAgainst monodansylcadaverine for in situ transglutaminase 1 assay.
Table 5. Secondary antibodies used for immunofluorescence and immunoblots
Antibody Host/ligand Applicationa Dilution Supplier Order num.
Alexa Fluorw 546 anti-rabbit Goat ICC 1:400 Molecular Probes A11035
Alexa Fluorw 488 anti-guinea pig Goat IHC 1:200 Molecular Probes A11073
Biotinylated anti-rat Rabbit Paraffin 1:200 Vector Laboratories BA-4001
Cy3TM anti-mouse Donkey ICC/IHC 1:200/1:1000 Jackson Dianova 715-165-150
Cy3TM- anti-rabbit Donkey IHC 1:1000 Jackson Dianova 711-165-152
Mouse HRP Goat WB 1:1000 Santa Cruz Sc-2005
Rabbit HRP Goat WB 1:1000 Santa Cruz Sc-2004
aICC, immunocytochemistry of HeLa cells; IHC, immunohistochemistry of tissue; WB, western blot.
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0.5% methylene blue/azure II (1:1) and 16% succrose in 0.5%
aqueous borax solution for 1–3 min at RT. Specimens were
finally rinsed with distilled H2O and dried at 858C. To visualize
epidermal glycogen, specimens were exclusively stained with
PAS without counterstaining.
For ultrastructural analysis, series of ultrathin Epon sections
were stained with lead citrate prior to electron microscopical
analysis (Zeiss EM 906E).
Light microscopical analysis of C. albicans invasion. Inocu-
lated skin samples grown on collagen gels were fixed with
4% formalin for 24 h and subsequently embedded in paraffin.
Sections (Microm, HM 355S) of 1 mm thickness were pre-
pared, deparaffinized and stained with PAS: 0.75% periodic
acid solution for 10 min, Schiff solution for 5 min. Following
rinsing and drying steps, sections were counterstained with
Mayer’s hemalaun (Roth). Sections were dehydrated and
mounted with Vitro-Clud (Langenbrink) and analyzed using
a Leica DMLB microscope.
Immunohistochemistry
To guarantee optimal morphology, mice were transcardially
perfused with 3–4% paraformaldehyde (PFA) in 0.1 M PBS,
pH 7.4 containing 2% PVP for 5–10 min. Interscapular skin
samples were postfixed for additional 30–60 min at 48C and
rinsed with PBS containing 2% PVP. These samples were
used for paraffin sections and after embedding in agar for
ultracryosemithin sections.
Paraffin sections. Specimens were dehydrated and embedded
in Paraplast Plus. Sections of 3–5 mm thickness were obtained
with a Microm HM 340E, then deparaffinized and subjected to
antigen retrieval with 10 mM sodium citrate and 0.5%
Tween-20 (pH 6.0) for 20 min at 968C. Ctsd, desmoglein 1/
2, desmoplakin 1/2, (pro)filaggrin, loricrin and CerS3 were
detected according to this protocol.
In situ mild alkaline hydrolysis. For extraction of protein-
bound SLs, paraffin sections were deparaffinized and
immersed in 100% ethanol followed by 100% methanol.
Mild alkaline methanolysis was performed (0.1 M KOH in
95% methanol) for 2 h at RT. Sections were carefully rinsed
in methanol, immersed in 100% ethanol, dehydrated and
rinsed in distilled water prior to antigen retrieval as described.
Desmoglein 1/2, loricrin and involucrin were subjected to this
protocol.
Ultracryosemithin sections. Microslicer sections of 600 mm
thickness were cryoprotected in sucrose (10%, 20%, 30%
and 2.3 M in 0.1 M PBS, pH 7.6 containing 10% PVP) prior
to be frozen in isopentane precooled with liquid nitrogen. Sub-
sequently, ultracryosemithin sections of 0.6–0.8 mm thickness
were prepared with a Leica Ultracut UCT equipped with a
Leica EMFCS and immunolabeled for F-actin, loricrin, des-
moglein 1/2 and involucrin.
For the detection of sensitive antigens, unfixed interscapular
skin samples were removed from anesthetized neonates and
quickly placed onto a straight aluminum foil, immersed in
OCT (Tissue Tek) and frozen in isopentane precooled with
liquid nitrogen. Cryosections of 3–5 mm thickness were
obtained with a Leica CM 3050S and subsequently fixed
with acetone for 10 min at RT. For the detection of claudin
1, sections were subjected to an antigen retrieval as described.
In order to localize cingulin and keratins 10 and 14, sections
were permeabilized with 0.1% Triton X-100 in PBS (v/v)
for 5 min and then blocked for 30 min with 10% fetal calf
serum.
Transglutaminase 1 activity assay. Transglutaminase activity
was localized as described with slight modifications (71).
Shortly, unfixed fresh skin cryosections of 3–5 mm thickness
were air-dried for 30 min and rinsed in PBS. Sections were
blocked with 1% BSA in 100 mM Tris buffer (pH 7.4) for
30 min, following 1 h incubation with 12 mM monodansylca-
daverine (Sigma) in 100 mM Tris buffer (pH 7.4) containing
5 mM calcium chloride. For negative controls, EDTA was
added into the substrate buffer to a final concentration of
20 mM. The enzymatic reaction was stopped with 10 mM
EDTA in PBS for 5 min. After rinsing in PBS, sections were
incubated for 3 h with anti-dansyl in 12% BSA-PBS. Subse-
quently, sections were washed and incubated for 45 min
with a secondary antibody in 12% BSA-PBS. Following
nuclear staining, specimens were mounted and directly ana-
lyzed.
Immunolabeling. Ultracryosemithin-, cryo- and paraffin sec-
tions were incubated with primary antibodies for 1–16 h at
48C or at RT (antibodies and the concentrations used are listed
in Table 4). Incubation with secondary antibodies (see
Table 5) was carried out for 1 h at RT.
For detection of nuclei and residual DNA, staining with
DAPI (20 ng/ml, Sigma) or Draq5TM (Biostatus) was per-
formed. Sections were mounted in either Fluoromount-G or
DakoCytomation fluorescent mounting medium. For negative
controls, PBS was used instead of primary antibodies. Sections
were visualized with the fluorescence microscope Biorevo
BZ-9000 (Keyence).
Proliferation assay with Ki67. Interfollicular keratinocyte pro-
liferation was assessed in paraffin sections of PFA fixed skin
using Ki67 as a marker (DakoAutostainer). Following
binding with primary antibody, sections were incubated with
a biotinylated anti-rat antibody and detected with alkaline
phosphatase-labeled streptavidin (Tables 4 and 5).
Terminal dUTP nick-end labeling. TUNEL assay was per-
formed on unfixed skin cryosections embedded in paraffin
using the in situ cell death detection kit (Roche) and the
recommendations provided by the manufacturer. After stain-
ing with Mayer’s hemalaun, the sections were analyzed
using a Leica DM-RBE microscope.
Localization of cholesterol and neutral lipids with filipin
and Nile red
Unfixed cryosections were stained with filipin (cholesterol) or
with Nile red (neutral lipids) as previously reported with slight
modifications (72,73). Sections were air-dried, rinsed, fixed in
4% phosphate-buffered formalin and stained either with
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freshly prepared filipin (10 mg/ml in PBS with 1% DMSO) for
2 h or with freshly prepared Nile red (5 mg/ml in 75% gly-
cerol) for 5 min. Specimens were mounted in Fluoromount-G
and analyzed (Biorevo BZ-9000, Keyence).
CerS3 localization in cultured HeLa cells
For subcellular localization of CerS3, HeLa cells were seeded
and transfected with lipofectamine on sterile 12 mm glass
cover slips. Following 24 h after transfection with
mCerS3-EGFP plasmid, cells were washed with chilled PBS.
CerS3 expressing cells were fixed with 3.5% PFA for 5 min
on ice and for 10 min at RT. After permeabilization with
methanol (2208C, 6 min) (74), blocking was carried out for
1 h with 3% BSA-PBS. Primary antibodies were incubated
for 1.5 h and secondary antibodies for 45 min at R. Immuno-
fluorescence images were acquired with a Leica TCS-SL
microscope using Leica Confocal software (version 2.61).
Generation and purification of CerS3 antibody
A synthetic peptide located at the C-terminus of mouse CerS3
protein was generated to immunize rabbits (PickCell Labora-
tories). The antiserum containing the polyclonal antibody
was purified by affinity chromatography using the correspond-
ing peptide coupled to N–hydroxysuccinimide-activated seph-
arose. The purified antibody was eluted with a low pH glycine
buffer (70 mM glycine in 0.6 mM phosphate buffer pH 2.7) and
concentrated using an Amicon Ultra 15 centrifugal filter
device (Millipore) at 4000g for 20 min. Protein concentration
was determined to 11.6 mg/ml.
Statistical analysis
Statistical analysis was performed using Student’s t-test, and
differences among groups were considered significant for
P, 0.05 (∗), P , 0.01 (∗∗) and P , 0.001 (∗∗∗).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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